|
 
 |
|
REVIEW ARTICLE |
|
|
|
| Year : 2013 | Volume
: 19
| Issue : 3 | Page : 279-281 |
| |
Hemoglobin E disorder: Newborn screening program
Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok, Thailand
| Date of Web Publication | 30-Oct-2013 |
Correspondence Address:
Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok
Thailand
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/0971-6866.120808
 Abstract | | |
Hemoglobin E (Hb E) disorder is an important kind of hemoglobinopathy. It can be seen around the world with the highest prevalence in Southeast Asia. The screening for this disorder becomes the public health policies in many countries. The screening can be performed in several population groups. The newborn screening program for Hb E disorder is an important issue in pediatric genetics. In this brief review, the author discusses on important laboratory tests for screening for Hb E disorder in newborn.
Keywords: Hemoglobin E, newborn, screening
How to cite this article:
Wiwanitkit V. Hemoglobin E disorder: Newborn screening program. Indian J Hum Genet 2013;19:279-81 |
| Introduction | |  |
The congenital hemoglobin disorder is an important group of a genetic disorder. [1] This becomes an important pediatric genetic problem that can be seen around the world. The considerable high incidence of the congenital hemoglobin disorder, comparing with other genetic disorders, draws the attention of the pediatricians to focus on this disorder. [2]
There are several kinds of congenital hemoglobin disorders. Hemoglobin E (Hb E) disorder is an important kind of hemoglobinopathy. [2] It can be seen around the world with the highest prevalence in Southeast Asia. [3] Although the disease form of this disease is not severe, only anemic presentation, it can be deadly if co-present with beta-thalassemia. [4],[5] The screening for this disorder becomes the public health policies in many countries. [6],[7] The screening can be performed in the several population groups. The newborn screening program for Hb E disorder is an important issue in pediatric genetics. [8],[9] In this brief review, the author discusses on important laboratory tests for screening for Hb E disorder in newborn.
| High Performance Liquid Chromatography Screening | | |
In general, High Performance Liquid Chromatography (HPLC) can be used for testing for the presence of abnormal hemoglobin. [10] Several hemoglobinopathies including to Hb E can be identified by HPLC. Dried blood spot specimens can be tested by HPLC. [11],[12] The HPLC is presently used in some countries like USA for neonatal screening for Hb E disorder. [11],[12] The screening is set due to the influx of migrant from Southeast Asia to USA in the recent years. [11],[12] Focusing on the technique, the automated HPLC can be available. [11],[12] In general, the positive result usually requires further investigation by pediatric hematologist for further assessment and ruling out the possible thalassemic co-presentation. [13] For discrimination, Lorey et al. studied the "Hb F and Hb E relative percentages obtained in the newborn's HPLC result" and reported that "the percentage of Hb E was markedly lower in neonates with Hb E/beta-thalassemia versus those, which were homozygous EE." [14]
| Hemoglobin Electrophoresis Screening | | |
Hemoglobin electrophoresis is a classical tool for determination of Hb E. This tool is still the present gold standard for screening in the several populations in the endemic areas. [15],[16],[17] The cord blood can be collected for classical gel electrophoresis and used in screening. [18] However, the use of this technique in the neonatal screening for Hb E disorder is not widely used because the present policy in an endemic country shifts to the pregnancy screening. [17]
| DichlorophenolIndophenol Precipitation Test Screening | | |
DichlorophenolIndophenol Precipitation (DCIP) is the simple test that can be used for determining unstable hemoglobinopathies including to Hb E. [19] In Thailand, the endemic area of Hb E, DCIP becomes that main tool for screening for Hb E disorder. However, as noted, the screening is recommended for the pregnant. [17],[20]
| Complete Blood Count Screening | | |
The use of Complete Blood Count (CBC) screening for Hb E in the newborn is also mentioned. There are some reports on the use of automated CBC analyzer for assessment of red blood cell parameters and usefulness in screening Hb E disorder. For the endemic area, very good screening result is reported. [21] However, the specificity is very poor. [21] For screening, the cord blood is required and this might be inconvenient. Furthermore, the availability of the automated analyzer is the main obstacle to implement this technique widely.
| Polymerase Chain Reaction Test Screening | | |
The molecular genetics analysis the new hope for screening for congenital genetic disorder including to hemoglobinopathy. [22] For Hb E screening, it is no doubt that post-coital test provides more reliable result comparing with those previously mentioned. Direct analysis of patient deoxyribonucleic acid samples can be performed and give rapid and highly accurate result. [23] However, focusing on the cost-effectiveness, the PCR test screening is not appropriate. [17]
| Other Screenings | | |
In addition to the already mentioned methods, there are also other alternative for screening of Hb E disorders. Isoelectric focusing, an adapted electrophoresis test, is the first alternative to be mentioned. [24],[25] It is proved for its reliability in cord blood testing. [24] The other method is tandem mass spectrometry. [25] The reliable result can be derived. [25] However, these two techniques are limitedly used in screening for any hemoglobinopathies due to the difficulty of the technique.
| Conclusion | | |
Hb E disorder is an important hemoglobinopathy with its highest prevalence in Southeast Asia. The screening for this disorder is included in the national policies of the endemic area, but the screening is recommended for the pregnant. For the newborn group, the screening for Hb E disorder is carried out in some settings like USA focusing on the migrant. [26],[27] The widely used technique is HPLC.
| References | | |
| 1. | Kohne E. Hemoglobinopathies: Clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int 2011;108:532-40. 
|
| 2. | Vichinsky E. Hemoglobin e syndromes. Hematology Am Soc Hematol Educ Program 2007;79-83.
|
| 3. | Fucharoen S, Winichagoon P. Haemoglobinopathies in Southeast Asia. Indian J Med Res 2011;134:498-506.
[PUBMED]  |
| 4. | Peters M, Heijboer H, Smiers F, Giordano PC. Diagnosis and management of thalassaemia. BMJ 2012;344:e228.
|
| 5. | Olivieri NF, Pakbaz Z, Vichinsky E. Hb E/beta-thalassaemia: A common and clinically diverse disorder. Indian J Med Res 2011;134:522-31.
[PUBMED] |
| 6. | Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Rev Hematol 2010;3:103-17.
|
| 7. | Lubin BH, Witkowska HE, Kleman K. Laboratory diagnosis of hemoglobinopathies. Clin Biochem 1991;24:363-74.
|
| 8. | Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci 2005;1054:18-24.
|
| 9. | Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF. Changes in the epidemiology of thalassemia in North America: A new minority disease. Pediatrics 2005;116:e818-25.
|
| 10. | Fucharoen S, Winichagoon P. Thalassemia and abnormal hemoglobin. Int J Hematol 2002;76 Suppl 2:83-9.
|
| 11. | Eastman JW, Lorey F, Arnopp J, Currier RJ, Sherwin J, Cunningham G. Distribution of hemoglobin F, A, S, C, E, and D quantities in 4 million newborn screening specimens. Clin Chem 1999;45:683-5.
|
| 12. | Eastman JW, Wong R, Liao CL, Morales DR. Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies. Clin Chem 1996;42:704-10.
|
| 13. | Hoppe CC. Newborn screening for hemoglobin disorders. Hemoglobin 2011;35:556-64.
|
| 14. | Lorey FW, Cunningham GC, Vichinsky E, Lubin B, Shafer F, Eastman J. Detection of Hb E/beta-thalassemia versus homozygous EE using high-performance liquid chromatography results from newborns. Biochem Med Metab Biol 1993;49:67-73.
|
| 15. | Paritpokee N, Wiwanitkit V, Suwansaksri J. Hemoglobin electrophoresis in Thai non-anemic pregnant subjects, a need for additional screening for hemoglobin E. Clin Chem Lab Med 2002;40:1176-7.
|
| 16. | Soogarun S, Sirimongkolsakul S, Mahakittikul B, Wiwanitkit V, Pradniwat P, Palasuwan A. Comparison of the KKU-DCIP diagnostic kit to the standard hemoglobin electrophoresis method for detection of hemoglobin E carriers. Lab Hematol 2004;10:189-90.
|
| 17. | Wiwanitkit V. A cost utility analysis of the right method for screening hemoglobin E among Thai pregnant women. Arch Gynecol Obstet 2006;274:88-90.
|
| 18. | Pung-amritt P, Tanphaichitr VS, Tachavanich K, Suwantol L, Glomglao W. Prevalence of HB E from cord blood samples and after one year follow-up. Southeast Asian J Trop Med Public Health 1999;30 Suppl 2:97-9.
|
| 19. | Sangkitporn S, Sangkitporn S, Sangnoi A, Supangwiput O, Tanphaichitr VS. Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E. Southeast Asian J Trop Med Public Health 2005;36:1538-42.
|
| 20. | Ratanasiri T, Charoenthong C, Komwilaisak R, Changtrakul Y, Fucharoen S, Wongkham J, et al. Prenatal prevention for severe thalassemia disease at Srinagarind Hospital. J Med Assoc Thai 2006;89 Suppl 4:S87-93.
|
| 21. | Tritipsombut J, Sanchaisuriya K, Fucharoen S, Fucharoen G, Siriratmanawong N, Pinmuang-ngam C, et al. Hemoglobin profiles and hematologic features of thalassemic newborns: Application to screening of alpha-thalassemia 1 and hemoglobin E. Arch Pathol Lab Med 2008;132:1739-45.
|
| 22. | Zhang YH, McCabe LL, Wilborn M, Therrell BL Jr, McCabe ER. Application of molecular genetics in public health: Improved follow-up in a neonatal hemoglobinopathy screening program. Biochem Med Metab Biol 1994;52:27-35.
|
| 23. | Johnson JP, Vichinsky E, Hurst D, Camber A, Lubin B, Louie E. Differentiation of homozygous hemoglobin E from compound heterozygous hemoglobin E-beta O-thalassemia by hemoglobin E mutation analysis. J Pediatr 1992;120:775-9.
|
| 24. | Charoenkwan P, Taweephol R, Sirichotiyakul S, Tantiprabha W, Sae-Tung R, Suanta S, et al. Cord blood screening for alpha-thalassemia and hemoglobin variants by isoelectric focusing in northern Thai neonates: Correlation with genotypes and hematologic parameters. Blood Cells Mol Dis 2010;45:53-7.
|
| 25. | Boemer F, Ketelslegers O, Minon JM, Bours V, Schoos R. Newborn screening for sickle cell disease using tandem mass spectrometry. Clin Chem 2008;54:2036-41.
|
| 26. | Lorey F. Asian immigration and public health in California: Thalassemia in newborns in California. J Pediatr Hematol Oncol 2000;22:564-6.
|
| 27. | Choy J, Foote D, Bojanowski J, Yamashita R, Vichinsky E. Outreach strategies for Southeast Asian communities: Experience, practice, and suggestions for approaching Southeast Asian immigrant and refugee communities to provide thalassemia education and trait testing. J Pediatr Hematol Oncol 2000;22:588-92.
|
|
|
|
|
|
|
|
|
